Skip to main content
Top
Published in: BMC Gastroenterology 1/2022

Open Access 01-12-2022 | Liver Resection | Research

Laparoscopic liver resection of segment 8 via a hepatic parenchymal transection-first approach guided by the middle hepatic vein

Authors: Nan You, Ke Wu, Jing Li, Lu Zheng

Published in: BMC Gastroenterology | Issue 1/2022

Login to get access

Abstract

Background

Pure laparoscopic liver resection (LLR) of segment 8 (S8) is still rarely performed due to the lack of an appropriate surgical approach. This article discusses the technical tips and operation methods for LLR of S8 via a hepatic parenchymal transection-first approach.

Methods

Clinical data of 22 patients who underwent LLR of S8 via a hepatic parenchymal transection-first approach guided by the middle hepatic vein (MHV) in the Second Affiliated Hospital, Third Military Medical University (Army Medical University) from May 2017 to February 2020 were retrospectively analyzed.

Results

The mean age was 51.1 ± 11.6 years; mean operation time, 186.6 ± 18.4 min; median blood loss, 170.0 ml (143.8–205.0 ml); and median length of hospital stay, 8.0 days (7.0–9.0 days). There was no case of open conversion. Pathologic findings revealed all cases of hepatocellular carcinoma (HCC). Pathology showed free surgical margins. Post-operative complications included liver section effusion, pleural effusion, pneumonia, intra-abdomen bleeding and bile leak. All the complications responded well to conservative treatment. No other abnormality was noted during outpatient follow-up examination. All patients survived tumor-free.

Conclusions

LLR of S8 is still quite challenging at present, and it is our goal to design a reasonable procedure with accurate efficacy and high safety. We use hepatic parenchymal transection-first approach guided by the MHV for LLR of S8. This technique overcomes the problem of high technical risk, greatly reduces the surgical difficulty and achieves technological breakthroughs, but there are still many problems worth further exploration.
Appendix
Available only for authorised users
Literature
1.
go back to reference Azagra JS, Goergen M, Gilbart E, Jacobs D. Laparoscopic anatomical (hepatic) left lateral segmentectomy-technical aspects. Surg Endosc. 1996;10(7):758–61. CrossRef Azagra JS, Goergen M, Gilbart E, Jacobs D. Laparoscopic anatomical (hepatic) left lateral segmentectomy-technical aspects. Surg Endosc. 1996;10(7):758–61. CrossRef
2.
go back to reference Kaneko H, Takagi S, Shiba T. Laparoscopic partial hepatectomy and left lateral segmentectomy: technique and results of a clinical series. Surgery. 1996;120(3):468–75.CrossRef Kaneko H, Takagi S, Shiba T. Laparoscopic partial hepatectomy and left lateral segmentectomy: technique and results of a clinical series. Surgery. 1996;120(3):468–75.CrossRef
3.
go back to reference Taniai N, Machida T, Yoshida H, Yoshioka M, Kawano Y, Shimizu T, et al. Role of the anterior fissure vein in ventral or dorsal resection at Segment 8 of liver. Eur J Surg Oncol. 2018;44(5):664–9.CrossRef Taniai N, Machida T, Yoshida H, Yoshioka M, Kawano Y, Shimizu T, et al. Role of the anterior fissure vein in ventral or dorsal resection at Segment 8 of liver. Eur J Surg Oncol. 2018;44(5):664–9.CrossRef
4.
go back to reference Schmelzle M, Krenzien F, Schöning W, Pratschke J. Laparoscopic liver resection: indications, limitations, and economic aspects. Langenbecks Arch Surg. 2020;405(6):725–35.CrossRef Schmelzle M, Krenzien F, Schöning W, Pratschke J. Laparoscopic liver resection: indications, limitations, and economic aspects. Langenbecks Arch Surg. 2020;405(6):725–35.CrossRef
5.
go back to reference Berardi G, Wakabayashi G, Igarashi K, Ozaki T, Toyota N, Tsuchiya A, et al. Full laparoscopic anatomical segment 8 resection for hepatocellular carcinoma using the Glissonian approach with indocyanine green dye fluorescence. Ann Surg Oncol. 2019;26(8):2577–8.CrossRef Berardi G, Wakabayashi G, Igarashi K, Ozaki T, Toyota N, Tsuchiya A, et al. Full laparoscopic anatomical segment 8 resection for hepatocellular carcinoma using the Glissonian approach with indocyanine green dye fluorescence. Ann Surg Oncol. 2019;26(8):2577–8.CrossRef
6.
go back to reference Kishi Y, Hasegawa K, Kaneko J, Aoki T, Beck Y, Sugawara Y, et al. Resection of segment VIII for hepatocellular carcinoma. Br J Surg. 2012;99(8):1105–12.CrossRef Kishi Y, Hasegawa K, Kaneko J, Aoki T, Beck Y, Sugawara Y, et al. Resection of segment VIII for hepatocellular carcinoma. Br J Surg. 2012;99(8):1105–12.CrossRef
7.
go back to reference Kim JH, Kim H. Pure laparoscopic anatomic resection of the Segment 8 ventral area using the transfissural Glissonean approach. Ann Surg Oncol. 2019;26(13):4608–9.CrossRef Kim JH, Kim H. Pure laparoscopic anatomic resection of the Segment 8 ventral area using the transfissural Glissonean approach. Ann Surg Oncol. 2019;26(13):4608–9.CrossRef
8.
go back to reference Xu Y, Chen M, Meng X, Lu P, Wang X, Zhang W, et al. Laparoscopic anatomical liver resection guided by real-time indocyanine green fluorescence imaging: experience and lessons learned from the initial series in a single center. Surg Endosc. 2020;34(10):4683–91.CrossRef Xu Y, Chen M, Meng X, Lu P, Wang X, Zhang W, et al. Laparoscopic anatomical liver resection guided by real-time indocyanine green fluorescence imaging: experience and lessons learned from the initial series in a single center. Surg Endosc. 2020;34(10):4683–91.CrossRef
9.
go back to reference Kim JH. Pure laparoscopic anatomical resection of the segment 8 dorsal area using the transparenchymal Glissonean approach (Video). Surg Oncol. 2019;31:99–100.CrossRef Kim JH. Pure laparoscopic anatomical resection of the segment 8 dorsal area using the transparenchymal Glissonean approach (Video). Surg Oncol. 2019;31:99–100.CrossRef
10.
go back to reference Jang JY, Han HS, Yoon YS, Cho JY, Choi Y, Lee W, et al. Three-dimensional laparoscopic anatomical Segment 8 liver resection with Glissonian approach. Ann Surg Oncol. 2017;24(6):1606–9.CrossRef Jang JY, Han HS, Yoon YS, Cho JY, Choi Y, Lee W, et al. Three-dimensional laparoscopic anatomical Segment 8 liver resection with Glissonian approach. Ann Surg Oncol. 2017;24(6):1606–9.CrossRef
11.
go back to reference Ide T, Matsunaga T, Tanaka T, Noshiro H. Feasibility of purely laparoscopic right anterior sectionectomy. Surg Endosc. 2021;35(1):192–9.CrossRef Ide T, Matsunaga T, Tanaka T, Noshiro H. Feasibility of purely laparoscopic right anterior sectionectomy. Surg Endosc. 2021;35(1):192–9.CrossRef
12.
go back to reference Ome Y, Honda G, Doi M, Muto J, Seyama Y. Laparoscopic anatomic liver resection of Segment 8 using intrahepatic Glissonean approach. J Am Coll Surg. 2019;230(3):e13–20.CrossRef Ome Y, Honda G, Doi M, Muto J, Seyama Y. Laparoscopic anatomic liver resection of Segment 8 using intrahepatic Glissonean approach. J Am Coll Surg. 2019;230(3):e13–20.CrossRef
13.
go back to reference Liu Q, Li J, Zhou L, Gu H, Wu K, You N, et al. Liver parenchyma transection-first approach for laparoscopic left hemihepatectomy: a propensity score matching analysis. World J Surg. 2020;45(2):615–23.CrossRef Liu Q, Li J, Zhou L, Gu H, Wu K, You N, et al. Liver parenchyma transection-first approach for laparoscopic left hemihepatectomy: a propensity score matching analysis. World J Surg. 2020;45(2):615–23.CrossRef
14.
go back to reference Kawabata Y, Hayashi H, Yano S, Tajima Y. Liver parenchyma transection-first approach in hemihepatectomy with en bloc caudate lobectomy for hilar cholangiocarcinoma: a safe technique to secure favorable surgical outcomes. J Surg Oncol. 2017;115(8):963–70.CrossRef Kawabata Y, Hayashi H, Yano S, Tajima Y. Liver parenchyma transection-first approach in hemihepatectomy with en bloc caudate lobectomy for hilar cholangiocarcinoma: a safe technique to secure favorable surgical outcomes. J Surg Oncol. 2017;115(8):963–70.CrossRef
15.
go back to reference Xiao L, Li JW, Zheng SG. Cranial-dorsal approach along the middle hepatic vein facilitating laparoscopic left hemihepatectomy. J Gastrointest Surg. 2021;25(3):868–9.CrossRef Xiao L, Li JW, Zheng SG. Cranial-dorsal approach along the middle hepatic vein facilitating laparoscopic left hemihepatectomy. J Gastrointest Surg. 2021;25(3):868–9.CrossRef
16.
go back to reference Joechle K, Vega EA, Okuno M, Simoneau E, Ogiso S, Newhook TE, et al. Middle hepatic vein roadmap for a safe laparoscopic right hepatectomy. Ann Surg Oncol. 2019;26(1):296.CrossRef Joechle K, Vega EA, Okuno M, Simoneau E, Ogiso S, Newhook TE, et al. Middle hepatic vein roadmap for a safe laparoscopic right hepatectomy. Ann Surg Oncol. 2019;26(1):296.CrossRef
17.
go back to reference Ni ZK, Lin D, Wang ZQ, Jin HM, Li XW, Li Y, et al. Precision liver resection: three-dimensional reconstruction combined with fluorescence laparoscopic imaging. Surg Innov. 2021;28(1):71–8.CrossRef Ni ZK, Lin D, Wang ZQ, Jin HM, Li XW, Li Y, et al. Precision liver resection: three-dimensional reconstruction combined with fluorescence laparoscopic imaging. Surg Innov. 2021;28(1):71–8.CrossRef
18.
go back to reference Zhu P, Liao W, Ding ZY, Luo HC, Zhang BH, Zhang WG, et al. Intraoperative ultrasonography of robot-assisted laparoscopic hepatectomy: initial experiences from 110 consecutive cases. Surg Endosc. 2018;32(10):4071–7.CrossRef Zhu P, Liao W, Ding ZY, Luo HC, Zhang BH, Zhang WG, et al. Intraoperative ultrasonography of robot-assisted laparoscopic hepatectomy: initial experiences from 110 consecutive cases. Surg Endosc. 2018;32(10):4071–7.CrossRef
19.
go back to reference Xiang C, Liu Z, Dong J, Sano K, Makuuchi M. Precise anatomical resection of the ventral part of Segment VIII. Int J Surg Case Rep. 2014;5(12):924–6.CrossRef Xiang C, Liu Z, Dong J, Sano K, Makuuchi M. Precise anatomical resection of the ventral part of Segment VIII. Int J Surg Case Rep. 2014;5(12):924–6.CrossRef
20.
go back to reference Fujikawa T, Kawamoto H, Kawamura Y, Emoto N, Sakamoto Y, Tanaka A. Impact of laparoscopic liver resection on bleeding complications in patients receiving antithrombotics. World J Gastrointest Endosc. 2017;9(8):396–404.CrossRef Fujikawa T, Kawamoto H, Kawamura Y, Emoto N, Sakamoto Y, Tanaka A. Impact of laparoscopic liver resection on bleeding complications in patients receiving antithrombotics. World J Gastrointest Endosc. 2017;9(8):396–404.CrossRef
21.
go back to reference Ferrero A, Lo Tesoriere R, Giovanardi F, Langella S, Forchino F, Russolillo N. Laparoscopic right posterior anatomic liver resections with Glissonean pedicle-first and venous craniocaudal approach. Surg Endosc. 2021;35(1):449–55.CrossRef Ferrero A, Lo Tesoriere R, Giovanardi F, Langella S, Forchino F, Russolillo N. Laparoscopic right posterior anatomic liver resections with Glissonean pedicle-first and venous craniocaudal approach. Surg Endosc. 2021;35(1):449–55.CrossRef
22.
go back to reference Monden K, Sadamori H, Hioki M, Sugioka A. Laparoscopic anatomic segmentectomy 8 using the outer-Laennec approach. Surg Oncol. 2020;35:299–300.CrossRef Monden K, Sadamori H, Hioki M, Sugioka A. Laparoscopic anatomic segmentectomy 8 using the outer-Laennec approach. Surg Oncol. 2020;35:299–300.CrossRef
Metadata
Title
Laparoscopic liver resection of segment 8 via a hepatic parenchymal transection-first approach guided by the middle hepatic vein
Authors
Nan You
Ke Wu
Jing Li
Lu Zheng
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2022
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-022-02289-8

Other articles of this Issue 1/2022

BMC Gastroenterology 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine